[Federal Register Volume 63, Number 7 (Monday, January 12, 1998)] [Notices] [Pages 1869-1870] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-652] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Clinical Laboratory Improvement Advisory Committee (CLIAC) and Subcommittee on Genetic Testing: Meetings In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meetings. Name: Subcommittee on Genetic Testing, Clinical Laboratory Improvement Advisory Committee (CLIAC). Times and Dates: 8:30 a.m.-4:30 p.m., January 27, 1998; 8:30 a.m.-4:30 p.m., January 28, 1998. Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: This subcommittee advises CLIAC on issues related to Genetic Testing. Matters To Be Discussed: Agenda items include a discussion on the definition of Genetic Testing under the Clinical Laboratory Improvement Amendments (CLIA) regulations; and the use of general versus specific CLIA requirements for pre-analytic, analytic, and post-analytic components of genetic testing. Agenda items are subject to change as priorities dictate. Name: Clinical Laboratory Improvement Advisory Committee. Times and Dates: 8:30 a.m.-4:30 p.m., January 29, 1998; 8 a.m.- 4:30 p.m., January 30, 1998. Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, E, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: This committee is charged with providing scientific and technical advice and guidance to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the need for, and the nature of, revisions to the standards under which clinical laboratories are regulated; the impact of proposed revisions to the standards; and the modification of the standards to accommodate the technological advances. Matters To Be Discussed: Agenda items include an update on CLIA implementation; CLIA requirements for the pre-analytic, analytic, and post-analytic components of Genetic Testing; International Guidelines for Proficiency Testing (PT) programs; and criteria for adding analytes to CLIA PT requirements. Agenda items are subject to change as priorities dictate. Contact Person: John C. Ridderhof, Dr. P.H., Division of Laboratory Systems, Public Health Practice Program Office, CDC, 4770 Buford Highway, NE, M/S G-25, Atlanta, Georgia 30341-3724, telephone 770/488-4674. [[Page 1870]] Dated: January 5, 1998. Carolyn J. Russell, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 98-652 Filed 1-9-98; 8:45 am] BILLING CODE 4163-18-P